STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

about

Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth

P2860

Q58728275-5C3D0AF5-3A14-423B-A028-87EEC94877FB

P2860

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

Item

http://www.wikidata.org/entity/Q52676604

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@en

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@nl

type

Item

label

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@en

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@nl

prefLabel

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@en

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

@nl

P1476

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma

@en

P2093

Filomena de Nigris

http://www.w3.org/2001/XMLSchema#string

Simona Romano

http://www.w3.org/2001/XMLSchema#string

Vittorio de Franciscis

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

Aptamer-Mediated Targeted Delivery of Therapeutics: An Update

The transcriptional network for mesenchymal transformation of brain tumours.

Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention.

Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.

The Jak2 small molecule inhibitor, G6, reduces the tumorigenic potential of T98G glioblastoma cells in vitro and in vivo.

Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.

An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.

P304

398-411

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OMTN.2017.12.021

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carla Lucia Esposito

Silvia Nuzzo

S Catuogno

P577

2017-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29499951

http://www.w3.org/2001/XMLSchema#string

P932

5862137

http://www.w3.org/2001/XMLSchema#string

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

about

P2860

P2860

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932